Vicente Diaz specializes in ocular inflammatory and infectious diseases. Dr. Diaz’ practice also includes Comprehensive Ophthalmology, treating ailments such as Dry Eye Syndrome, Glaucoma, and Cataracts. His research interests include novel immunomodulatory therapies for the treatment of non-infectious inflammatory disease, management of Stevens Johnson’s Syndrome, a potentially lethal autoimmune disease, and innovative therapies in glaucoma.

Dr. Diaz is Chief of Ophthalmology at the Yale Health Plan, addressing the eye needs of the Yale faculty, students, employees, and their families. He is the Director of Diversity and Inclusion for the Department of Ophthalmology and Visual Science at Yale University. Dr. Diaz is also Director of Ophthalmology for the Bridgeport Hospital Burn Unit, where he oversees the care of all patients with Stevens Johnson's Syndrome in the state of Connecticut.

Dr. Diaz was voted among the top eye doctors in Fairfield County in the Fairfield Advocate’s 2012 and 2013 reader’s polls. After graduating from Ophthalmology residency at Yale University, he completed a fellowship in Ocular Immunology & Infectious Disease at The New York Eye & Ear Infirmary where he was recently on the clinical and research faculty. He is currently a co-investigator on several FDA clinical trials of novel immunomodulatory therapies for inflammatory diseases, sponsored by companies such as Abott, Novartis, and Lux Biosciences.

Dr. Diaz is also active in the surrounding community, with a presence that has grown consistently throughout his tenure in the Tri-State, including an appointment as keynote speaker at the 2011 Puerto Rican Festival in Bridgeport, Connecticut. Dr. Diaz founded the La Unidad Latina Medical Guild and was the architect of their annual medical mission to the Dominican Republic, Guatemala, and Honduras where he performs surgery, teaches medical residents, and cares for patients in need; the team created by Dr. Diaz sees between 3,000 – 5,000 patients abroad annually. Dr. Diaz received his BA from Brown University, his MD from Yale School of Medicine, and his MBA at Yale School of Management.